Enliven Therapeutics shares owned by Susquehanna International
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Susquehanna International
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.9M | 90k | 20.47 |
| 2025-06-30 | $1.1M | 56k | 20.06 |
| 2025-03-31 | $884k | 45k | 19.68 |
| 2024-12-31 | $349k | 16k | 22.50 |
| 2024-06-30 | $203k | 8.7k | 23.37 |
| 2023-09-30 | $149k | 11k | 13.66 |
| 2023-03-31 | $4.3M | 197k | 21.90 |